Elutia, Inc. - Class A Common Stock (ELUT)
2.6200
+0.0700 (2.75%)
Elutia, Inc. is a biotechnology company focused on developing and commercializing innovative therapies that aim to address unmet medical needs
The company specializes in regenerative medicine, particularly in the areas of tissue engineering and cell therapy, working to create advanced solutions that enhance the body's natural healing processes. Through rigorous research and development, Elutia is dedicated to transforming the treatment landscape for various conditions, improving patient outcomes, and contributing to the advancement of healthcare technologies.
ELUT Stock Earnings: Elutia Misses EPS, Misses Revenue for Q2 2024investorplace.com
ELUT stock results show that Elutia missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 7, 2024
7 Growth Stocks to Buy for Under $5 for Massive Gainsinvestorplace.com
Although growth stocks under $5 are inherently risky and unpredictable, their very nature also facilitates robust upside potential.
Via InvestorPlace · July 11, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · June 17, 2024
ELUT Stock Earnings: Elutia Misses EPS, Beats Revenue for Q1 2024investorplace.com
ELUT stock results show that Elutia missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 9, 2024
ELUT Stock Earnings: Elutia Misses EPS, Misses Revenue for Q4 2023investorplace.com
ELUT stock results show that Elutia missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 7, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · October 4, 2023
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023benzinga.com
Via Benzinga · September 28, 2023
Earnings Scheduled For March 7, 2024benzinga.com
Companies Reporting Before The Bell • CI&T (NYSECINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via Benzinga · March 7, 2024
Earnings Scheduled For November 13, 2023benzinga.com
Companies Reporting Before The Bell • Sohu.com (NASDAQSOHU) is expected to report earnings for its third quarter. • Dixie Gr NASDAQ:DXYNNASDAQDXYN)
Via Benzinga · November 13, 2023
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · September 25, 2023
Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Sessionbenzinga.com
Gainers MicroAlgo Inc. (NASDAQMLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to boost the performance and efficiency of research institutions.
Via Benzinga · September 22, 2023
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionbenzinga.com
Gainers MSP Recovery, Inc. (NASDAQLIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday.
Via Benzinga · September 21, 2023
Why Murphy Canyon Acquisition Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarketbenzinga.com
Gainers Near Intelligence, Inc. (NASDAQNIR) shares rose 34.1% to $0.2801 in pre-market trading after falling 42% on Wednesday. Near Intelligence recently named its General Counsel, Jay Angelo, to also serve as the company’s Chief Privacy Officer.
Via Benzinga · September 21, 2023
Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionbenzinga.com
Gainers MSP Recovery, Inc. (NASDAQLIFW) shares jumped 104.5% to $0.1916.
Via Benzinga · September 20, 2023
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · September 20, 2023
Why Fresh Tracks Therapeutics Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarketbenzinga.com
Gainers TransCode Therapeutics, Inc. (NASDAQRNAZ) shares rose 70.2% to $0.8937 in pre-market trading after falling 10% on Tuesday.
Via Benzinga · September 20, 2023
Dow Falls 150 Points; AutoZone Earnings Top Viewsbenzinga.com
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 150 points on Tuesday. The Dow traded down 0.48% to 34,457.36 while the NASDAQ fell 0.28% to 13,672.29. The S&P 500 also fell, dropping, 0.34% to 4,438.52.
Via Benzinga · September 19, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · September 19, 2023